Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-16-017783
Filing Date
2016-01-15
Accepted
2016-01-15 20:06:32
Documents
1
Period of Report
2015-10-20

Document Format Files

Seq Description Document Type Size
1 FORM 5 - edgar.html 5  
1 FORM 5 - edgar.xml 5 4875
  Complete submission text file 0001179110-16-017783.txt   6342
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEGERION PHARMACEUTICALS, INC. 101 MAIN STREET, SUITE 1850 CAMBRIDGE MA 02142
Business Address
Rothera Mark (Reporting) CIK: 0001550424 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-35969 | Film No.: 161346734